Cargando…

The Addition of Manganese Porphyrins during Radiation Inhibits Prostate Cancer Growth and Simultaneously Protects Normal Prostate Tissue from Radiation Damage

Radiation therapy is commonly used for prostate cancer treatment; however, normal tissues can be damaged from the reactive oxygen species (ROS) produced by radiation. In separate reports, we and others have shown that manganese porphyrins (MnPs), ROS scavengers, protect normal cells from radiation-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, Arpita, Zhu, Yuxiang, Tong, Qiang, Kosmacek, Elizabeth A., Lichter, Eliezer Z., Oberley-Deegan, Rebecca E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789331/ https://www.ncbi.nlm.nih.gov/pubmed/29370088 http://dx.doi.org/10.3390/antiox7010021

Ejemplares similares

MnTE-2-PyP Suppresses Prostate Cancer Cell Growth via H(2)O(2) Production
por: Zhu, Yuxiang, et al.
Publicado: (2020)

MnTnBuOE-2-PyP protects normal colorectal fibroblasts from radiation damage and simultaneously enhances radio/chemotherapeutic killing of colorectal cancer cells
por: Kosmacek, Elizabeth A., et al.
Publicado: (2016)

MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses
por: Chatterjee, Arpita, et al.
Publicado: (2020)

Adipocytes protect fibroblasts from radiation-induced damage by adiponectin secretion
por: Kosmacek, Elizabeth A., et al.
Publicado: (2020)

CT vs. bioluminescence: A comparison of imaging techniques for orthotopic prostate tumors in mice
por: Myers, Molly S., et al.
Publicado: (2022)

Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis
por: Shrishrimal, Shashank, et al.
Publicado: (2019)

The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues
por: Shrishrimal, Shashank, et al.
Publicado: (2017)

MnTE-2-PyP protects fibroblast mitochondria from hyperglycemia and radiation exposure
por: Chatterjee, Arpita, et al.
Publicado: (2022)

NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression
por: Buttari, Brigitta, et al.
Publicado: (2022)

MnTnBuOE-2-PyP treatment protects from radioactive iodine (I-131) treatment-related side effects in thyroid cancer
por: Patel, Anery, et al.
Publicado: (2019)

Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils
por: Costanzo-Garvey, Diane L., et al.
Publicado: (2022)

Sex‐based differences in the severity of radiation‐induced arthrofibrosis
por: Rodman, Samuel N., et al.
Publicado: (2022)

The Role of Gold Nanorods in the Response of Prostate Cancer and Normal Prostate Cells to Ionizing Radiation—In Vitro Model
por: Musielak, Marika, et al.
Publicado: (2020)

The ion channel, TRPM2, contributes to the pathogenesis of radiodermatitis
por: Perraud, Anne-Laure, et al.
Publicado: (2018)

Chemotherapy and radiation for prostate cancer
por: Hurwitz, Mark David
Publicado: (2018)

Radiation therapy for prostate cancer
por: Buyyounouski, Mark K.
Publicado: (2018)

Toxicity of Tomotherapy-Based Simultaneous Integrated Boost in Whole-Pelvis Radiation for Prostate Cancer
por: You, Sei Hwan, et al.
Publicado: (2015)

Effects of Manganese Porphyrins on Cellular Sulfur Metabolism
por: Olson, Kenneth R., et al.
Publicado: (2020)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

Radiation‐induced sarcoma after radiation therapy for prostate adenocarcinoma
por: Wakabayashi, Kohei, et al.
Publicado: (2019)

Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells
por: Lindner, Diana, et al.
Publicado: (2022)

Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma
por: Horiguchi, Hiroto, et al.
Publicado: (2014)

Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells
por: Gan, Si-Shun, et al.
Publicado: (2017)

Pravastatin reduces radiation-induced damage in normal tissues
por: Doi, Hiroshi, et al.
Publicado: (2017)

Regional Responses in Radiation-Induced Normal Tissue Damage
por: Voshart, Daniëlle C., et al.
Publicado: (2021)

Diagnostic radiation procedures and risk of prostate cancer
por: Myles, P, et al.
Publicado: (2008)

Molecular Targets for Radiation Oncology in Prostate Cancer
por: Wang, Tao, et al.
Publicado: (2011)

Tissue Biomarkers for Prostate Cancer Radiation Therapy
por: Tran, PT, et al.
Publicado: (2012)

Pouchitis Associated With Pelvic Radiation for Prostate Cancer
por: Kulkarni, Geeta, et al.
Publicado: (2016)

SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair
por: El Bezawy, Rihan, et al.
Publicado: (2020)

Analysis of Prostate Deformation during a Course of Radiation Therapy for Prostate Cancer
por: Nakazawa, Takuya, et al.
Publicado: (2015)

Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis
por: Parikh, Nainesh, et al.
Publicado: (2020)

Mechanistic Studies on the Epoxidation of Alkenes by Macrocyclic Manganese Porphyrin Catalysts
por: Chen, Xiaofei, et al.
Publicado: (2022)

Monte Carlo dose verification of prostate patients treated with simultaneous integrated boost intensity modulated radiation therapy
por: Dogan, Nesrin, et al.
Publicado: (2009)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

Nanoformulation of the superoxide dismutase mimic, MnTnBuOE-2-PyP(5+), prevents its acute hypotensive response
por: Schlichte, Sarah L., et al.
Publicado: (2020)

Endothelial perturbations and therapeutic strategies in normal tissue radiation damage
por: Korpela, Elina, et al.
Publicado: (2014)

Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control
por: Saracino, Biancamaria, et al.
Publicado: (2014)

Prostate radiation in non-metastatic castrate refractory prostate cancer provides an interesting insight into biology of prostate cancer
por: Pascoe, Abigail C, et al.
Publicado: (2012)

Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Vu, Charles C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6v2nlgsvibgmvir51rvnu730tl